We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials.
- Authors
Raschetti, Roberto; Albanese, Emiliano; Vanacore, Nicola; Maggini, Marina
- Abstract
Mild cognitive impairment (MCI) refers to a transitional zone between normal ageing and dementia. Despite the uncertainty regarding the definition of MCI as a clinical entity, clinical trials have been conducted in the attempt to study the role of cholinesterase inhibitors (ChEIs) currently approved for symptomatic treatment of mild to moderate Alzheimer disease (AD), in preventing progression from MCI to AD. The objective of this review is to assess the effects of ChEIs (donepezil, rivastigmine, and galantamine) in delaying the conversion from MCI to Alzheimer disease or dementia.
- Publication
PLoS medicine, 2007, Vol 4, Issue 11, pe338
- ISSN
1549-1676
- Publication type
Journal Article
- DOI
10.1371/journal.pmed.0040338